Virbagen Omega Evrópusambandið - íslenska - EMA (European Medicines Agency)

virbagen omega

virbac s.a. - raðbrigða omega interferón af kattgengu uppruna - Ónæmisörvandi, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. hjá köttum sem sýkt voru af fiv var dauðsföll lágt (5%) og hafði ekki áhrif á meðferðina.

SmofKabiven extra Nitrogen Innrennslislyf, fleyti Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

smofkabiven extra nitrogen innrennslislyf, fleyti

fresenius kabi ab - alaninum inn; argininum inn; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum asetat; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; calcii chloridum dihydricum inn; natrii glycerophosphas; magnesium sulfate heptahydrate; kalii chloridum; natrii acetas; zinc sulphate heptahydrate; glucose monohydrate; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; fish oil rich in omega-3 acids - innrennslislyf, fleyti

SmofKabiven Innrennslislyf, fleyti Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

smofkabiven innrennslislyf, fleyti

fresenius kabi ab - alaninum inn; argininum inn; glycinum inn; histidinum inn; isoleucinum inn; leucinum inn; lysinum asetat; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; calcii chloridum; natrii glycerophosphas; magnesii sulfas; kalii chloridum; natrii acetas; zinci sulfas; glucosum; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; piscis oleum omega-3 acidis abundans - innrennslislyf, fleyti

SmofKabiven Elektrolytfri Innrennslislyf, fleyti Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

smofkabiven elektrolytfri innrennslislyf, fleyti

fresenius kabi ab - alaninum inn; argininum inn; glycinum inn; histidinum inn; isoleucinum inn; leucinum inn; lysinum asetat; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; glucosum; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; piscis oleum omega-3 acidis abundans - innrennslislyf, fleyti

SmofKabiven Perifer Innrennslislyf, fleyti Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

smofkabiven perifer innrennslislyf, fleyti

fresenius kabi ab - glucosum; alaninum inn; argininum inn; glycinum inn; histidinum inn; isoleucinum inn; leucinum inn; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; kalii chloridum; zinci sulfas; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; fish oil rich in omega-3 acids; calcii chloridum; lysinum inn; magnesii sulfas; natrii acetas; natrii glycerophosphas - innrennslislyf, fleyti

Vistide Evrópusambandið - íslenska - EMA (European Medicines Agency)

vistide

gilead sciences international limited - cidófóvír - cytomegalovirus retinitis - veirueyðandi lyf til almennrar notkunar - vistide er ætlað til meðferðar við cýtómegalóveiru retinitis hjá sjúklingum með fengið ónæmisbrestsheilkenni (aids) og án skerta nýrnastarfsemi. vistide ætti aðeins að nota þegar aðrir lyf eru talin óviðeigandi.

Livtencity Evrópusambandið - íslenska - EMA (European Medicines Agency)

livtencity

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirus sýkingar - veirueyðandi lyf til almennrar notkunar - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). Íhuga ætti að opinbera leiðsögn á réttri notkun af veirum.

Kabiven Innrennslislyf, fleyti Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

kabiven innrennslislyf, fleyti

fresenius kabi ab - soya-bean oil refined; glucosum; alaninum inn; arginine; aspartic acid; glutamic acid; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum inn; methioninum inn; phenylalaninum inn; proline; serine; threoninum inn; tryptophanum inn; tyrosinum inn; valine; natrii glycerophosphas; magnesii sulfas; kalii chloridum; sodium acetate trihydrate; calcium chloride dihydrate - innrennslislyf, fleyti

Vazkepa Evrópusambandið - íslenska - EMA (European Medicines Agency)

vazkepa

amarin pharmaceuticals ireland limited - icosapent ethyl - dýrarannsóknir - lipid breytandi lyf - indicated to reduce cardiovascular risk as an adjunct to statin therapy.

Valtrex Filmuhúðuð tafla 250 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

valtrex filmuhúðuð tafla 250 mg

glaxosmithkline pharma a/s - valaciclovirum hýdróklóríð - filmuhúðuð tafla - 250 mg